These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 14529558)

  • 21. Antihypertensive Therapies and Left Ventricular Hypertrophy.
    Soliman EZ; Prineas RJ
    Curr Hypertens Rep; 2017 Sep; 19(10):79. PubMed ID: 28929454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive drug treatment and fibrinolytic function.
    Lottermoser K; Weisser B; Hertfelder HJ; Wöstmann B; Vetter H; Düsing R
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):378-84. PubMed ID: 9544880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Impact of antihypertensive treatment on target organs].
    Fregoso Padilla J
    Arch Cardiol Mex; 2002; 72 Suppl 1():S58-63. PubMed ID: 12001872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits of combination therapy in hypertensive patients with associated coronary artery disease: a subgroup with specific demands.
    Morisco C; Lembo G; Sarno D; Argenziano L; Fratta L; Rozza F; Trimarco B
    J Cardiovasc Pharmacol; 1998; 31 Suppl 2():S27-33. PubMed ID: 9605599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced risk of thromboembolic disease in hypertension from platelet hyperfunction and decreased fibrinolytic activity: has antihypertensive therapy any influence?
    Winther K; Gleerup G; Hedner T
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S21-4. PubMed ID: 1376829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
    Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction to haemostasis from a pharmacodynamic perspective.
    Kluft C; Burggraaf J
    Br J Clin Pharmacol; 2011 Oct; 72(4):538-46. PubMed ID: 21342216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological modulation of platelet function in hypertension.
    Blann AD; Nadar S; Lip GY
    Hypertension; 2003 Jul; 42(1):1-7. PubMed ID: 12782643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.
    Zanchetti A; Thomopoulos C; Parati G
    Circ Res; 2015 Mar; 116(6):1058-73. PubMed ID: 25767290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of thrombogenic effects of drugs.
    Zbinden G
    Annu Rev Pharmacol Toxicol; 1976; 16():177-88. PubMed ID: 180876
    [No Abstract]   [Full Text] [Related]  

  • 36. Is hypertension a prothrombotic state?
    Varughese GI; Lip GY
    Curr Hypertens Rep; 2005 Jun; 7(3):168-73. PubMed ID: 15913489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive treatment and stroke prevention: are angiotensin receptor blockers superior to other antihypertensive agents?
    Armario P; de la Sierra A
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):197-204. PubMed ID: 19443514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM; Schmieder RE
    Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are there benefits to specific antihypertensive drug therapy?
    Cushman WC
    Am J Hypertens; 2003 Nov; 16(11 Pt 2):31S-35S. PubMed ID: 14625158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shortcomings of current antihypertensive therapy.
    Hansson L
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):84S-87S. PubMed ID: 2021456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.